Page last updated: 2024-10-27

gliclazide and Cardiotoxicity

gliclazide has been researched along with Cardiotoxicity in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research Excerpts

ExcerptRelevanceReference
"Cardiotoxicity and lung injury are two of the main side effects of oxidative stress following radiotherapy in patients with thoracic region cancer."5.72Radioprotective effects of gliclazide against irradiation-induced cardiotoxicity and lung injury through inhibiting oxidative stress. ( Arzani, S; Farzipour, S; Hosseinimehr, SJ; Talebpour Amiri, F, 2022)
"Cardiotoxicity and lung injury are two of the main side effects of oxidative stress following radiotherapy in patients with thoracic region cancer."1.72Radioprotective effects of gliclazide against irradiation-induced cardiotoxicity and lung injury through inhibiting oxidative stress. ( Arzani, S; Farzipour, S; Hosseinimehr, SJ; Talebpour Amiri, F, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Talebpour Amiri, F1
Arzani, S1
Farzipour, S1
Hosseinimehr, SJ1

Other Studies

1 other study available for gliclazide and Cardiotoxicity

ArticleYear
Radioprotective effects of gliclazide against irradiation-induced cardiotoxicity and lung injury through inhibiting oxidative stress.
    Medical oncology (Northwood, London, England), 2022, Sep-07, Volume: 39, Issue:12

    Topics: Animals; Antioxidants; Cardiotoxicity; Gliclazide; Lung Injury; Mice; Oxidative Stress

2022